Literatur
Crouse JR, Raichlen JS, Riley WA et al. for the METEOR Study Group (2007) Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. The METEOR Trial. JAMA 297: 1344–1353
Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) Executive summary of the third report of the national cholesterol education program (NCEP). JAMA 285: 2486–2497
National Institute for Health and Clinical Excellence (2008) Lipid modification. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE Clinical Guideline No. 67: 1–37
Smilde TJ, Wissen S van, Wollersheim H et al. (2001) Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomized, double-blind trial. Lancet 357: 577–581
Interessenkonflikte
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berthold, H., Nitschmann, S. Therapie der familiären Hypercholesterinämie mit oder ohne Ezetimib. Internist 49, 1274–1276 (2008). https://doi.org/10.1007/s00108-008-2215-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-008-2215-8